HYRIMOZ

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 5b88f0b9b45524e0
Drug Approval Canada Name: HYRIMOZ
Product Name: HYRIMOZ
Status: Marketed
Status Date: 2024-04-17
Original Market Date: 2024-04-17
Din: 02542366
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 90:24.16.92
Atc Original: L04AB04 ADALIMUMAB
Atc Name: l 04 ab 04
Aig Number: 0150364002
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

ADALIMUMAB

80 MG / 0.8 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5b88f0b9b45524e0

Type

Standard